Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
scPharmaceuticals Inc | SCPH | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
4.35 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 4.25 - 12.75 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 4.35 | USD |
scPharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
156.84M | 36.05M | - | 13.59M | -54.81M | -1.52 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
scPharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SCPH Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.50 | 4.79 | 4.27 | 4.50 | 129,042 | -0.15 | -3.33% |
1 Month | 4.97 | 5.33 | 4.25 | 4.79 | 172,666 | -0.62 | -12.47% |
3 Months | 5.03 | 6.54 | 4.25 | 5.30 | 220,936 | -0.68 | -13.52% |
6 Months | 5.84 | 6.71 | 4.25 | 5.41 | 294,122 | -1.49 | -25.51% |
1 Year | 9.50 | 12.75 | 4.25 | 7.45 | 316,023 | -5.15 | -54.21% |
3 Years | 6.80 | 12.75 | 3.48 | 7.04 | 229,912 | -2.45 | -36.03% |
5 Years | 3.65 | 12.75 | 2.78 | 6.98 | 172,319 | 0.70 | 19.18% |
scPharmaceuticals Description
scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's lead product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure. |